Biotechnology RETA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 14, 2020 in the Class Action Filed on Behalf of Reata Pharmaceuticals, Inc. Limited Shareholders October 21, 2020
Biotechnology Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mesoblast, Loop Industries, Turquoise Hill Resources, and Reata Pharmaceuticals and Encourages Investors to Contact the Firm October 21, 2020
Biotechnology ROSEN, GLOBAL INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – BMRN October 21, 2020
Biotechnology Ascendis Pharma A/S Announces Presentations for its Endocrinology Rare Disease Clinical Programs at Upcoming Medical Conferences October 21, 2020
Biotechnology Allakos Announces Publication of Results from the Phase 2 Study of Lirentelimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis (ENIGMA) in the New England Journal of Medicine October 21, 2020
Biotechnology GLNG, GTX & BMRN Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines October 21, 2020
Biotechnology RETA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Reata Pharmaceuticals, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm October 21, 2020
Biotechnology Alkermes (ALKS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release October 21, 2020
Biotechnology BridgeBio Pharma, Inc. and the University of Colorado Anschutz Medical Campus Collaborate to Advance Medicines for Genetically Driven Diseases October 21, 2020
Biotechnology Salk Institute and BridgeBio Pharma Collaborate to Advance Therapies for Genetically Driven Disease October 21, 2020
Search
Biotechnology
